Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trialSEYMOUR, Matthew T; THOMPSON, Lindsay C; WASAN, Harpreet S et al.Lancet (British edition). 2011, Vol 377, Num 9779, pp 1749-1759, issn 0140-6736, 11 p.Article

Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS TrialBRAUN, Michael S; RICHMAN, Susan D; THOMPSON, Lindsay et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5519-5528, issn 0732-183X, 10 p.Article

Irinotecan/Fluorouracil Combination in First-Line Therapy of Older and Younger Patients With Metastatic Colorectal Cancer : Combined Analysis of 2,691 Patients in Randomized Controlled TrialsFOLPRECHT, Gunnar; SEYMOUR, Matthew T; SCHUBERT, Ute et al.Journal of clinical oncology. 2008, Vol 26, Num 9, pp 1443-1451, issn 0732-183X, 9 p.Article

Lack of pharmacokinetic interaction between 5-fluorouracil and oxaliplatinJOEL, Simon P; PAPAMICHAEL, Dimitri; RICHARDS, Fiona et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 1, pp 45-54, issn 0009-9236, 10 p.Article

Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy TrialsBLANKE, Charles D; BOT, Brian M; THOMAS, David M et al.Journal of clinical oncology. 2011, Vol 29, Num 20, pp 2781-2786, issn 0732-183X, 6 p.Article

Predictive Biomarkers of Chemotherapy Efficacy in Coorectal Cancer : SResults From the UK MRC FOCUS TrialBRAUN, Michael S; RICHMAN, Susan D; PARMAR, Mahesh K. B et al.Journal of clinical oncology. 2008, Vol 26, Num 16, pp 2690-2698, issn 0732-183X, 9 p.Article

Severe Sequence-Specific Toxicity When Capecitabine Is Given After Fluorouracil and LeucovorinHENNIG, Ivo M; NAIK, Jay D; SEYMOUR, Matthew T et al.Journal of clinical oncology. 2008, Vol 26, Num 20, pp 3411-3417, issn 0732-183X, 7 p.Article

Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fluorouracil-refractory metastatic colon cancerCHESTER, John D; JOEL, Simon P; CHEESEMAN, Susan L et al.Journal of clinical oncology. 2003, Vol 21, Num 6, pp 1125-1132, issn 0732-183X, 8 p.Article

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3: MRC COIN trialMAUGHAN, Timothy S; ADAMS, Richard A; KAY, Edward et al.Lancet (British edition). 2011, Vol 377, Num 9783, pp 2103-2114, issn 0140-6736, 12 p.Article

Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal CancerSARGENT, Daniel J; KÖHNE, Claus Henning; DOUILLARD, Jean-Yves et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 1948-1955, issn 0732-183X, 8 p.Article

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS) : a randomised controlled trialSEYMOUR, Matthew T; MAUGHAN, Timothy S; MEADE, Angela M et al.Lancet (British edition). 2007, Vol 370, Num 9582, issn 0140-6736, 105-107, 143-152 [13 p.]Article